# Spectral CT Clinical Trial Protocol

> **NCT05017233** · NA · TERMINATED · sponsor: **Philips (China) Investment CO., LTD** · enrollment: 51 (actual)

## Conditions studied

- CT Scanning

## Interventions

- **DEVICE:** Spectral CT

## Key facts

- **NCT ID:** NCT05017233
- **Lead sponsor:** Philips (China) Investment CO., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-04
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-02-12
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Investigational product had been released in NMPA, Sponsor decided to terminate the study aligned with investigator
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017233, "Spectral CT Clinical Trial Protocol". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05017233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*